CordenPharma is committed to providing flexible solutions for your product success through a legacy of combined API development and contract manufacturing capabilities and specialised technologies in state-of-the-art cGMP facilities.
CordenPharma’s chemical development scientists have the skill and experience to meet a wide range of outsourcing needs including route scouting, process development, scale-up, optimisation and custom synthesis.
Our facilities provide reliable cGMP contract manufacturing of APIs and advanced intermediates within the full spectrum of cGMP synthesis and chemical manufacturing services ranging from production of early stage clinical trial materials to product launch and commercialisation.
For generic drug companies we supply more than 20 APIs for multiple therapeutic indications and work well in advance of drug patent expiration to provide non-infringing processes and support in the filing of Drug Master Files or Certificates of European Pharmacopoeia.
With a long track record of success in handling highly potent intermediates and APIs, CordenPharma utilises sophisticated technologies and the combined capabilities of multiple cGMP facilities to produce highly potent pharmaceutical products and their ingredients.
Oligonucleotide Development & Manufacturing
CordenPharma provides customers with dedicated technologies such as aseptic technique in advanced sterile manufacturing facilities for the production of sterile APIs including cephalosporins and penicillins.
Our network of cGMP manufacturing facilities support your peptide projects with a legacy of experience in manufacturing synthetic peptides for both small and large-scale production, including the largest peptide production capacity worldwide.
CordenPharma is a reliable supplier of high-purity building blocks shipped to a global customer base for use in peptide API productions of any complexity.
Our combined specialised core competencies in both synthetic peptide and lipid cGMP production make us an expert supplier in the manufacturing of therapeutic lipopeptides at various chemical stages from discovery to commercialisation.
We draw upon a resource of combined capabilities and scientific know-how to supply a growing demand of rare sugars with innovative carbohydrate products to be used as building blocks and conjugates.
CordenPharma’s scientists have mastered the chemical total synthesis of complex phospholipid derivatives to bring a unique product line of fully synthetic phospholipids manufactured in cGMP facilities on a multi-gram to multi-kilogram scale.
We offer expert analytical development, validation and regulatory support for our contracted customers at all stages of product development.